Linc AB (LINC.ST) stock: key figures, P/E, revenue and dividend

Industrials · Environmental & Facilities Services · Sweden · ISIN SE0015949433

Price
71.00 SEK
Market cap
4.11 bn SEK
P/E (2025)
–
P/S (2025)
423.71
Dividend yield
0.00 %
Net margin
-4,118.37 %
Return on equity (ROE)
-9.02 %
Return on assets (ROA)
-9.00 %

Linc AB financials

Fiscal year20242025
Revenue12,000.00 SEK9.70 m SEK
Gross profit-7.88 m SEK6.29 m SEK
Operating income1.28 bn SEK-422.82 m SEK
EBIT1.28 bn SEK-406.77 m SEK
Net income1.30 bn SEK-399.65 m SEK
Diluted EPS – continuing operations22.48 SEK-6.90 SEK

Full history since 2018, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Linc AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.99 million), the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB was founded in 1991 and based in Stockholm, Sweden.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.